double-blind trial deflazacort versus prednisone juvenile chronic arthritis bone-sparing effect deflazacort Thirty-four children juvenile chronic rheumatoid arthritis double-blind study deflazacort oxazolone derivative prednisone vs prednisone glucocorticoid therapy year mg/d prednisolone mg days children study Bone density trends spine dual photon absorptiometry forearm single photon quantitative tomography intervals Trends velocities bone soft tissue growth spine bone growth indices soft tissue growth covariance analysis significant advantage deflazacort spinal bone mineral growth surface area weight part due temporary interruption weight children deflazacort gain height comparable prednisone group children groups catch-up growth children spinal bone mineral growth velocities height weight first year deflazacort spinal bone mineral content level appropriate height weight Further observations advantage anti-inflammatory effects glucocorticoids similar 